Paradigm Health logo
Blog

11.11.2026

Bringing Clinical Trial Opportunities Closer to Veterans

For a veteran facing cancer, a clinical trial may be the only opportunity to consider a new treatment option. But finding a suitable trial, and getting to a site where it’s running, can be difficult, particularly when patients live far from VA health centers. U.S. clinical trial statistics bear this out: U.S. veterans are dramatically underrepresented in clinical trials, despite the high-quality healthcare veterans can receive.

The U.S. Department of Veterans Affairs has made important investments in clinical research and in helping more veterans find trial opportunities. To expand the reach of healthcare sites dedicated to veterans’ care, the VA established the Community Care Network (CCN), a group of more than one million providers nationwide contracted by the VA and equipped to provide high-quality care to veterans.1 VA practitioners may refer veterans to these community providers so patients can receive VA-covered care closer to home. When these community care providers offer trials, veterans have the opportunity to participate in trials without significant disruptions to their routine care.

VA Community Care Providers within the Paradigm Health Network

Several of Paradigm Health’s provider partners, including Florida Cancer Specialists & Research Institute (FCS), are part of the VA’s Community Care Network.

So for this Veterans Day, the Paradigm Health team set out to understand what happens when its provider partners identify veterans and their family members for potential clinical trial eligibility. The analysis offers an encouraging look at what an AI-enabled platform can do to connect veterans and their families to trials.

Over a year-long period, November 5, 2025 - November 5, 2026, Paradigm Health’s platform screened 11,762 veterans and their covered family members for potential eligibility in clinical trials running at the community health centers where they receive care. Patients in the analysis were identified based on insurance records.

  • Of those patients, the platform identified 741 as potential matches for one or more trials running and enrolling at the Paradigm Health community sites where they were being treated. Those 741 patients were subsequently confirmed by clinical teams as likely eligible.
  • Among those 741 likely eligible patients, 141 enrolled in a clinical trial.
  • The remaining 600 patients continued to be monitored by their care teams and the platform for future enrollment, informed by data from ongoing doctor visits, clinical milestones, and laboratory results.

Florida Cancer Specialists & Research Institute

Florida Cancer Specialists & Research Institute, a Paradigm Health provider partner, is part of the VA’s Community Care Network and has a long-standing commitment to expanding clinical trial opportunities for veterans. FCS uses Paradigm Health’s AI-enabled platform to help its clinical research teams identify patients who may be eligible for studies running at FCS.

Lucio N. Gordan, MD, President and Managing Physician of FCS has long prioritized making FCS a premier oncology care provider for Florida’s veterans.

“Veterans deserve access to the full spectrum of cancer care, including the opportunity to participate in clinical research,” said Dr. Gordan. “By bringing clinical trials closer to where veterans live and receive care, and equipping community oncology teams with tools like Paradigm Health’s clinical trial recruitment platform, we can help remove barriers, identify potential opportunities earlier, and support more informed conversations between patients and their physicians about whether a clinical trial is right for them.”

Helping care teams find potential matches

Identifying the right trial for a patient is complex. Eligibility criteria vary from study to study, and a patient’s medical history and condition can change over time. Reviewing those details across a practice’s patient population takes considerable clinical and research staff time.

Paradigm Health’s platform helps by reviewing patient information against criteria for trials available at their sites and identifying potential patient matches for clinical teams to evaluate. The platform can continuously assess patients’ eligibility, so that clinical research teams can focus less on chart review and more on patient engagement.

Clinicians and research teams review potential matches surfaced by the platform, determine eligibility, and discuss appropriate options with patients.

Building on the findings

The 141 enrollments represent the veterans and families who chose to participate in research at partner community-care sites. When clinical research is accessible where patients already see their doctors, and care teams have tools to efficiently evaluate trial opportunities, research can become an integrated part of veteran care.

The analysis also highlights an important opportunity for trial sponsors: pharmaceutical sponsors can increase enrollment of veterans to clinical trials by bringing more trials to the community-care sites that are part of the VA’s Community Care Network. Sponsors can leverage Paradigm Health’s AI-enabled patient identification and matching capabilities to help more veterans learn about research.

Clinical trials are an essential part of providing the most advanced care, particularly in oncology. Compared to the general U.S. population, veterans of the U.S. armed forces are more likely to be diagnosed with cancer, according to the CDC.2 In order to provide access to the best possible care, clinical trials need to be available to veterans no matter where they receive their care.

“The VA’s Community Care Network is an important part of how veterans receive care closer to home, and it also represents an opportunity to bring clinical research closer to where veterans live,” said Kent Thoelke, Founder and Chief Executive Officer of Paradigm Health. “Our analysis shows what is possible when technology helps care teams identify potential trial opportunities as part of routine care. The opportunity now is to build on that model so that more veterans, wherever they receive care, have the opportunity to consider whether a clinical trial is right for them.”

Sources:

  1. https://department.va.gov/vha/community-care/partnerships/community-care-network/
  2. https://www.cdc.gov/nchs/data/nhsr/nhsr153-508.pdf